Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • One-Year Cost Component for Atrial Fibrillation & Non AF Medicare Patients
    One-Year Cost Component for AF & Non AF Medicare Patients  
  • The risk of stroke attributable to atrial fibrillation by age
    The risk of stroke attributable to atrial fibrillation increases from 1.5% for those ages 50 to 59 to 23.5% for those ages 80 to 89.  
  • Risk of ischemic stroke in AFib patients
    The risk of ischemic stroke in nonvalvular atrial fibrillation patients is 2 to 7 times (200% to 700%) greater than in those without the disease.  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…  
  • Lifetime risk of atrial fibrillation
    At age 80, the remaining lifetime risk of atrial fibrillation is around 22%.